A polymorphism in NFKB1 is associated with improved effect of interferon-{alpha} maintenance treatment of patients with multiple myeloma after high-dose treatment with stem cell support

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt